How can therapies targeting interleukin-17 affect treatment outcomes in dogs with inflammatory conditions?
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901660702343168 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | The evidence indicates a potential role for interleukin-17 targeting therapies in managing inflammatory conditions in dogs, but further canine-specific trials are necessary to confirm efficacy and safety. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17922644 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | How can therapies targeting interleukin-17 affect treatment outcomes in dogs with inflammatory conditions? Tripdatabase interleukin-17 therapies dogs inflammatory conditions treatment outcomes immunology veterinary medicine The evidence indicates a potential role for interleukin-17 targeting therapies in managing inflammatory conditions in dogs, but further canine-specific trials are necessary to confirm efficacy and safety. |
| title | How can therapies targeting interleukin-17 affect treatment outcomes in dogs with inflammatory conditions? |
| topic | interleukin-17 therapies dogs inflammatory conditions treatment outcomes immunology veterinary medicine |
| url | https://doi.org/10.5281/zenodo.17922644 |